TASEKO MINES LTD (TGB)

CA8765111064 - Common Stock

1.375  +0.06 (+4.96%)


Fundamental Rating

2

Overall TGB gets a fundamental rating of 2 out of 10. We evaluated TGB against 951 industry peers in the Metals & Mining industry. Both the profitability and financial health of TGB have multiple concerns. TGB is quite expensive at the moment. It does show a decent growth rate.

Note: TGB has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

0

TGB has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for TGB.

VS Industry

Valuation

Valuation Rating

3

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Forward Price/Earnings Ratio of 14.78 indicates a correct valuation of TGB.
When comparing the current price to the book value of TGB, we can conclude it is valued correctly. It is trading at 1.51 times its book value.

Compared to an average industry price book ratio of 1.56, TGB is valued in line with its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 6.53, TGB is valued more expensive than its industry peers.
VS Industry

Price/Book (1.51) VS Industry: 51% outperformed.

272.66
0.03

Enterprise Value/ EBITDA (10.64) VS Industry: 34% outperformed.

569.39
0.23

Growth

Growth Rating

6

TGB is expected to show a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 1743520.00% yearly.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Based on estimates for the next 5 years, TGB will show a quite strong growth in Revenue. The Revenue will grow by 17.23% on average per year.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The Revenue has decreased by -9.61% in the past year.
TGB shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 0.69% yearly.
TGB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.00%.
The earnings per share for TGB have been decreasing by -99.95% on average. This is quite bad

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-99.95% N/A -100% 3638908498915361000% 25431575568.12% 46332800% 1743520%
Revenue0.69% 5.96% -9.61% 30.36% 18.64% 20.46% 17.23%

Health

Health Rating

2

A Current Ratio of 2.14 indicates that TGB has no problem at all paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 2.55.
A Quick Ratio of 1.31 indicates that TGB should not have too much problems paying its short term obligations.
Compared to an average industry Quick Ratio of 2.08, TGB is worse placed to pay its short term obligations than its industry peers.

TGB has one of the worst Debt to Equity ratios in its industry. 99% of its industry peers require less debt for financing their operations.
Based on the Altman-Z score of 0.64, we must say that TGB is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.27, TGB is in worse financial health than its industry peers.
TGB has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for TGB.
VS Industry

Debt/Equity (1.6) VS Industry: 1% outperformed.

9.62
0.00

Quick Ratio (1.31) VS Industry: 37% outperformed.

0.00
178.59

Current Ratio (2.14) VS Industry: 43% outperformed.

0.00
178.59

Altman-Z (0.64) VS Industry: 37% outperformed.

-2,971.54
2,354.89

Dividend

Dividend Rating

0

No dividends for TGB!.

TASEKO MINES LTD

NYSEARCA:TGB (6/2/2023, 1:05:25 PM)

1.375

+0.06 (+4.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-03 2023-05-03/amc
Earnings (Next)08-07 2023-08-07/bmo
Inst Owners17.28%
Inst Owner Change0.55%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap396.57M
Analysts80
Price Target2.28 (65.82%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)199.01%
Min EPS beat(2)199.01%
Max EPS beat(2)199.01%
EPS beat(4)1
Avg EPS beat(4)-378.37%
Min EPS beat(4)-1288.12%
Max EPS beat(4)199.01%
Revenue beat(2)N/A
Avg Revenue beat(2)-3.63%
Min Revenue beat(2)-4.22%
Max Revenue beat(2)-3.04%
Revenue beat(4)N/A
Avg Revenue beat(4)-7.99%
Min Revenue beat(4)-16.72%
Max Revenue beat(4)-3.04%
PT rev (1m)-0.2%
PT rev (3m)6.62%
EPS NQ rev (1m)-16.67%
EPS NQ rev (3m)-24.98%
EPS NY rev (1m)0%
EPS NY rev (3m)285.45%
Revenue NQ rev (1m)6%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)18.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.78
P/S 1.37
P/FCF N/A
P/OCF 6.62
P/B 1.51
P/tB 1.53
EV/EBITDA 10.64
EPS(TTM)N/A
EYN/A
EPS(NY)0.09
Fwd EY6.77%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)0.21
OCFY15.1%
SpS1
BVpS0.91
TBVpS0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 2.68%
ROICexc 3%
ROICexgc 3.02%
OM 10.11%
PM N/A
GM 13.85%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.52%
ROIC(5y)N/A
ROICexc(3y)5.64%
ROICexc(5y)N/A
ROICexgc(3y)5.67%
ROICexgc(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-21.8%
ROICexc growth 3YN/A
ROICexc growth 5Y-21.79%
OM growth 3YN/A
OM growth 5Y-18.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-16.62%
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Debt/EBITDA 6.42
Cap/Depr 286.55%
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.31
Altman-Z 0.64
F-Score2
WACC9.27%
ROIC/WACC0.33
Cap/Depr(3y)153.84%
Cap/Depr(5y)128.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-100%
EPS 3YN/A
EPS 5Y-99.95%
EPS growth Q2Q-60%
EPS Next Y3638908498915361000%
EPS Next 2Y25431575568.12%
EPS Next 3Y46332800%
EPS Next 5Y1743520%
Revenue growth 1Y-9.61%
Revenue growth 3Y5.96%
Revenue growth 5Y0.69%
Revenue growth Q2Q-2.29%
Revenue Next Year30.36%
Revenue Next 2Y18.64%
Revenue Next 3Y20.46%
Revenue Next 5Y17.23%
EBIT growth 1Y-72.36%
EBIT growth 3YN/A
EBIT growth 5Y-18.43%
EBIT Next Year159.27%
EBIT Next 3Y69.35%
EBIT Next 5Y48.98%
FCF growth 1Y-165.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.5%
OCF growth 3Y24.02%
OCF growth 5Y-17.38%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA